International Stem Financials
| ISCO Stock | USD 0.10 0.01 9.09% |
With this module, you can analyze International financials for your investing period. You should be able to track the changes in International Stem individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
International |
Understanding current and past International Stem Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of International Stem's financial statements are interrelated, with each one affecting the others. For example, an increase in International Stem's assets may result in an increase in income on the income statement.
The data published in International Stem's official financial statements typically reflect International Stem's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving International Stem's quantitative information. For example, before you start analyzing numbers published by International accountants, it's essential to understand International Stem's liquidity, profitability, and earnings quality within the context of the Biotechnology space in which it operates.
International Stem Stock Summary
International Stem competes with Mesabi Trust, Nutanix, Morningstar Unconstrained, Thrivent High, and Via Renewables. International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in North America, Asia, Europe, and internationally. International Stem Cell Corporation was founded in 2001 and is headquartered in San Diego, California. International Stem operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 26 people.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| ISIN | US4603782016 |
| Business Address | 9745 Businesspark Avenue, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.internationalstemcell.com |
| Phone | 760 940 6383 |
| Currency | USD - US Dollar |
International Stem Key Financial Ratios
International Stem's financial ratios allow both analysts and investors to convert raw data from International Stem's financial statements into concise, actionable information that can be used to evaluate the performance of International Stem over time and compare it to other companies across industries.| Return On Equity | -6.92 | |||
| Return On Asset | -0.0685 | |||
| Target Price | 0.54 | |||
| Number Of Employees | 26 | |||
| Beta | 0.65 |
International Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining International Stem's current stock value. Our valuation model uses many indicators to compare International Stem value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across International Stem competition to find correlations between indicators driving International Stem's intrinsic value. More Info.International Stem Cell is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value International Stem by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for International Stem's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.International Stem Cell Systematic Risk
International Stem's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. International Stem volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on International Stem Cell correlated with the market. If Beta is less than 0 International Stem generally moves in the opposite direction as compared to the market. If International Stem Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one International Stem Cell is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of International Stem is generally in the same direction as the market. If Beta > 1 International Stem moves generally in the same direction as, but more than the movement of the benchmark.
International Stem December 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of International Stem help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of International Stem Cell. We use our internally-developed statistical techniques to arrive at the intrinsic value of International Stem Cell based on widely used predictive technical indicators. In general, we focus on analyzing International OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build International Stem's daily price indicators and compare them against related drivers.
| Downside Deviation | 28.74 | |||
| Information Ratio | 0.1263 | |||
| Maximum Drawdown | 166.07 | |||
| Value At Risk | (33.33) | |||
| Potential Upside | 42.86 |
Other Information on Investing in International OTC Stock
International Stem financial ratios help investors to determine whether International OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in International with respect to the benefits of owning International Stem security.